ROC has amended its plan to list an initial public offering on the Nasdaq, and is now expecting to raise up to $17.1 million.
The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. Imagine you are redesigning your living space. You could hire an interior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results